Frazier Life Sciences Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164M | Hold |
3,800,457
| – | – | 6.56% | 4 |
|
|
2025
Q1 | $131M | Hold |
3,800,457
| – | – | 6% | 5 |
|
|
2024
Q4 | $104M | Buy |
3,800,457
+40,000
| +1% | +$1.1M | 4.33% | 9 |
|
|
2024
Q3 | $95.7M | Buy |
3,760,457
+127,853
| +4% | +$3.26M | 3.84% | 9 |
|
|
2024
Q2 | $92M | Buy |
3,632,604
+217,000
| +6% | +$5.5M | 4.3% | 7 |
|
|
2024
Q1 | $106M | Buy |
3,415,604
+689,655
| +25% | +$21.3M | 4.46% | 7 |
|
|
2023
Q4 | $110M | Hold |
2,725,949
| – | – | 5.88% | 5 |
|
|
2023
Q3 | $71.9M | Buy |
2,725,949
+737,073
| +37% | +$19.4M | 4.77% | 6 |
|
|
2023
Q2 | $34.2M | Buy |
1,988,876
+817,226
| +70% | +$14.1M | 2.04% | 12 |
|
|
2023
Q1 | $19.4M | Buy |
+1,171,650
| New | +$19.4M | 1.41% | 20 |
|